Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	n.A.	16.63	n.A.
Graham Fair Price	100.00	4.29	0.00
PEG	0.00	0.00	0.00
Price/Book	100.00	2.35	0.00
Price/Cash Flow	100.00	37.48	0.00
Prices/Earnings	100.00	6.85	0.00
Price/Sales	100.00	5.18	0.00
Price/FCF	100.00	37.48	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	-0.25	0.71	0.71
Operating Margin	-8.05	0.23	0.25
ROA	100.00	0.06	0.00
ROE	0.00	0.09	100.00
ROIC	0.00	0.08	100.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.01	0.96	6572.50
EPS QOQ	-1.00	0.00	inf
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	-0.03	1.13	3650.63
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	n.A.	64.98	n.A.
Days Sales Outstanding (DSO)	n.A.	59.98	n.A.
Inventory Turnover	0.00	1.39	100.00
Debt/Capitalization	0.00	0.02	100.00
Quick Ratio	0.00	2.27	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	0.00	3.08	100.00
Cash	0.00	1.22	100.00
Capex	0.00	-0.07	-100.00
Free Cash Flow	0.00	0.19	100.00
Revenue	0.00	1.40	100.00
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	0.00	2.63	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	n.A.	-2.81	n.A.
Naive Interpretation	Member

06 - Financial Health · Bad

Rating